Sudden bilateral vision loss in a COVID-19 patient: A case report

Atum, Mahmut; Demiryürek, Bekir Enes

doi:10.4103/ijo.ijo_3706_20

Cited by 6 publications

(14 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Finally, 29 studies were included in the systematic review [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ] and two in the meta-analysis [ 9 , 23 ]. The included studies provided data on the number of participants with “visual loss” developed during COVID-19, and the meta-analysis included two studies [ 9 , 23 ] with 288 COVID-19 patients.…”

Section: Resultsmentioning

confidence: 99%

“…The articles included in this systematic review were published between 28 April 2020 and 22 February 2022. We assessed two cross-sectional studies [ 9 , 23 ], twenty-four case reports [ 8 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 24 , 25 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 36 ], and three case series [ 14 , 26 , 35 ]. The number of participants ranged from one (case reports) to 199 (cross-sectional studies), with 84 out 318 COVID-19 patients experiencing “visual loss”.…”

Section: Resultsmentioning

confidence: 99%

“…”Visual loss” in COVID-19 patients was reported in a few articles. Nonetheless, it has been observed that its onset may be due to viral neurotropism and indirect immunologic and neurovascular effects [ 8 , 9 , 10 , 11 , 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 , 26 , 27 , 28 , 29 , 30 , 31 , 32 , 33 , 34 , 35 , 36 ].…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

“Vision Loss” and COVID-19 Infection: A Systematic Review and Meta-Analysis

Ripa

Motta

Schipa

et al. 2022

Vision

View full text Add to dashboard Cite

Background: Visual impairment in terms of reduced visual acuity and “visual loss” has been reported as an atypical symptom in patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. This systematic review and meta-analysis aims to assess the cumulative incidence of “visual loss” during coronavirus disease 2019 (COVID-19) and review the current evidence regarding “visual loss” caused by SARS-CoV-2 infection. Methods: We performed a systematic review and meta-analysis of studies following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We systematically searched the PubMed, Embase, and Scopus databases for relevant studies published that clearly described “vision loss” and SARS-CoV-2 infection. All studies reporting concomitant “vision loss” and laboratory-confirmed SARS-CoV-2 infection were included. Meta-analyses were conducted using the measurement of risk and a 95% confidence interval for each study. Results: Our search identified 1143 manuscripts published in the English language. After study screening, twenty-nine articles were selected: two cross-sectional studies, twenty-four case reports, and three case series. A random-effect meta-analysis demonstrated that the pooled “visual loss” cumulative incidence in COVID-19 patients was 0.16 (95% CI 0.12–0.21). The quality rating of the cross-sectional studies averaged four out of the maximum score on the Newcastle–Ottawa scale. Conclusions: COVID-19 infection might cause “visual loss”. Even if the current evidence is limited, ophthalmological assessment should be promptly provided to all patients experiencing visual impairment symptoms during SARS-CoV-2 infection.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

“Vision Loss” and COVID-19 Infection: A Systematic Review and Meta-Analysis

Ripa

Motta

Schipa

et al. 2022

Vision

View full text Add to dashboard Cite

show abstract

“…Another aspect that deserves attention is the expedited mucormycosis publications, of which one was the largest multicentric database from India. [ 6 ] Neuro-ophthalmology was another subspecialty that had a deep impact through various expedited case reports in the form of Holmes-Adie syndrome,[ 41 ] intracranial hypertension,[ 42 ] and occipital infarct[ 43 ] associated with COVID-19. The interesting add-on was research methodology-based publication in the form of publication trends of COVID-19- and non-COVID-19-related articles in IJO,[ 10 ] scientometrics, citation analysis of COVID-19 literature,[ 9 ] and scientometrics of ophthalmology COVID-19 publications,[ 44 ] which had commentaries by experts and a large number of downloads and reads.…”

Section: Discussionmentioning

confidence: 99%

Analysis of COVID-19 publications in the Indian Journal of Ophthalmology during two years of the pandemic and their impact on ophthalmic literature

Gurnani

Kaur

2022

Indian Journal of Ophthalmology

View full text Add to dashboard Cite

Purpose: To perform a comprehensive analysis of COVID-19 publications published in the Indian Journal of Ophthalmology (IJO) during the two years of the pandemic and to study their impact on ophthalmic literature. Methods: A retrospective analysis was performed of all expedited COVID-19 articles published in IJO from April 2020 to March 2022. The data was obtained from the official website of IJO, editor IJO monthly emails, and PubMed database. The data was then extracted as XML into Microsoft Access for scientometric analysis. The expedited articles were segregated into different categories: original, review, case report/series, letter to the editor, commentary, current ophthalmology, consensus criteria, perspective, innovations, ophthalmic images, photoessays, research methodology, and surgical techniques. The monthly data was analyzed and COVID-19 articles were assessed for subspecialty-wise distribution, number of citations, monthly growth rate, and their impact on ophthalmic literature. Results: A total of 431 COVID-19 related articles were published during the study period. The majority of the articles were letters to the editor (158, 36.65%) followed by original articles (97, 22.50%), and commentaries (53, 12.29%). The least were perspectives and ophthalmic images (2, 0.46%) each followed by consensus criteria (1, 0.23%). The maximum publications came in July 2020 (44, 10.20%) followed by December 2021 (37, 8.58%) and October 2021 (36, 8.35%), and the least were in April 2020 (1, 0.23%). Considering subspecialty, a majority of the articles were related to general ophthalmology (156, 36.19%), and the least was in oncology (2, 0.46%). The maximum number of citations were attracted by original articles (97, 1146 (11.81)), which were approximately 1.5 times higher than the letters to the editor (158, 743 (4.70)) and 3 times higher than review articles (9, 387 (43)). Among specialties, the maximum number of citations were gathered by general ophthalmology (156, 1320 (8.46)) followed by oculoplasty (36, 592 (16.44)) due to the concurrent mucormycosis epidemic. Conclusion: IJO opened a window of opportunity for authors by publishing quality expedited articles. Evidence-based orbital mucormycosis and general ophthalmology publications gathered most of the attention due to their heterogeneous presentation. The peak of the first wave (June–July 2020) and the October and December 2021 issues had maximum number of COVID-19 articles.

show abstract

“…If the posterior visual pathways are involved, then the stroke will be associated with a binocular visual field defect 8 . Retinal emboli manifesting as a central retinal artery occlusion, branch occlusion, or ophthalmic artery occlusion in monocular loss of vision 9 .…”

Section: Vascularmentioning

confidence: 99%

Neuro-Ophthalmic Implications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Infection and Vaccination

Petzold

2022

Asia-Pacific Journal of Ophthalmology

View full text Add to dashboard Cite

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic created a unique opportunity to study the effects of infection and vaccination on disease. The year 2020 was dominated by infection and its consequences. The year 2021 was dominated by vaccination and its consequences. It will still take several years for full maturation of databases required for robust epidemiological studies. Therefore, this review on the implications for neuro-ophthalmology draws on resources presently available including reported adverse reactions to vaccination. Illustrative clinical cases are presented. The spectrum of pathology following infection with SARS-CoV-2 falls into 4 main categories: autoimmune, vascular, sequelae of brain damage, and miscellaneous. This review is exhaustive, but the most common conditions discussed relate to headaches and associated symptoms; vertigo, diplopia, and nystagmus; vascular complications of the eye and brain; cranial nerve (mono-)neuropathies; photophobia, ocular discomfort, and optic neuritis. Of the 36 main adverse reactions reviewed, vaccine-induced immune thrombotic thrombocytopenia is a novel complication requiring specific hematological management. Updated diagnostic criteria are summarized. It is relevant to remember taking a medication history because of side effects and to recognize the relevance of comorbidities. The clinical assessment can frequently be performed virtually. Consensus recommendations on telemedicine and the virtual assessment are summarized in a practical and compressed format. The review concludes with an epidemiological tetralogy to interrogate, in future studies, associations with (1) SARS-CoV-2 pandemic infection, (2) SARS-CoV-2 worldwide vaccination, and (3) the possibility of a rebound effect of infections in the pandemic aftermath.

show abstract

Sudden bilateral vision loss in a COVID-19 patient: A case report

Cited by 6 publications

References 9 publications

“Vision Loss” and COVID-19 Infection: A Systematic Review and Meta-Analysis

“Vision Loss” and COVID-19 Infection: A Systematic Review and Meta-Analysis

Analysis of COVID-19 publications in the Indian Journal of Ophthalmology during two years of the pandemic and their impact on ophthalmic literature

Neuro-Ophthalmic Implications of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Infection and Vaccination

Contact Info

Product

Resources

About